The physician had worked at Walter Reed Hospital and 4 former colleagues accused him of falsifying information and forging their signatures on a report to a medical journal last year. The army took no action since he is retired.
Medtronic since has suspended his contract (smart move there) but did not disclose how much he was paid or any additional details. Infuse, a bioengineered bone-growth product sold by Medronic is the product in question, stating that is was superior to conventional bone grafts. This sound pretty heavy when 4 people that worked with you are now in disagreement, or maybe they were not compensated in the same fashion. BD
Dr. Timothy R. Kuklo, a former Army physician accused of falsifying research involving injured soldiers, has taken a leave of absence from the Washington University School of Medicine in St. Louis and its affiliated hospitals, the medical school said Friday.
Dr. Kuklo, an associate professor of orthopedic surgery, will not be performing operations, conducting research or teaching students, said a medical school spokeswoman, Joni Westerhouse. The university granted the leave, she said, so that Dr. Kuklo “can focus on responding to queries about his research and consulting.”
Dr. Kuklo has been a consultant to Medtronic, and the company has also paid for some of his research and writings.
Medtronic, the nation’s largest medical-device maker, announced Wednesday that it was suspending Dr. Kuklo’s consulting contract, which had started in August 2006 as he left Walter Reed for the university position. Medtronic has declined to provide details of its consulting payments but said it had no involvement with the disputed research.
Army investigators said Dr. Kuklo’s study had cast Infuse, a bioengineered bone-growth product sold by Medronic, in a misleadingly favorable light compared with conventional bone grafts, in repairing severely shattered shin bones of American soldiers injured in the Iraq war.
Former Army Doctor Accused of Research Fraud Takes Leave From University - NYTimes.com
0 comments :
Post a Comment